Announcements

Drs. Patricia Berg, Valerie Hu, Rong Li, and William Weglicki became members of the GW Chapter of the National Academy of Inventors (NAI).

A patent based on the work from Dr. William Weglicki’s team has led to a Phase 2a clinical trial of HT-001 for the treatment of skin toxicities associated with Epidermal Growth Factor Receptor Inhibitors (EGFRi).

A patent based on the work from Dr. Rong Li’s team has led to a Phase 1 clinical trial PRTH-101, a Novel DDR1 Inhibitor for the Treatment of Immune-Excluded Solid Tumors.

Dr. Wenge Zhu received the 2023 GW Cancer Center Award for Outstanding Scientist.

Dr. Jiyoung Lee received the 2023 GW Cancer Center Award for Junior Faculty Research.

Dr. Sabysachi Sen has been elected as a Fellow of the National Lipid Association.

Drs. Mamta Gupta, Anelia Horvath, and Robel Kahsay have been promoted to Associate Professor, Research Professor, and Associate Research Professor, respectively.

Wholehearted congratulations to Dr. Jack Vanderhoek on his Emeritus Professor status.

Wholehearted congratulations to Dr. Wenge Zhu on his promotion to the rank of tenured Professor

This research, published in Blood Advances defines how tumor microenvironment network of tumor-associated macrophages and the mantle cell lymphoma contributes to disease progression and alternative macrophage polarization.